Infarct in the Heart: What's MMP-9 Got to Do with It?

Mediha Becirovic-Agic1,2, Upendra Chalise1,2, Michael J Daseke1,2,3

  • 1Center for Heart and Vascular Research, Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68102, USA.

Biomolecules
|April 3, 2021
PubMed

Insights

Matrix metalloproteinase 9 (MMP-9) plays a complex role in heart attack wound healing. Targeting only its harmful effects, not all actions, is key for future therapies.

Area of Science:

  • Cardiovascular biology
  • Wound healing research
  • Biochemistry

Background:

  • Matrix metalloproteinase 9 (MMP-9) is linked to myocardial infarction (MI) mortality and cardiac dysfunction.
  • Clinical trials of MMP-9 inhibitors have yielded disappointing results.

Purpose of the Study:

  • To review the multifaceted roles of MMP-9 in myocardial infarction (MI) wound healing.
  • To emphasize the need for targeted inhibition of MMP-9's detrimental actions.

Main Methods:

  • Literature review of studies on MMP-9 in cardiac repair.
  • Analysis of MMP-9 secretion by various cardiac cells.
  • Examination of MMP-9's effects on inflammation, neovascularization, and scar formation.

Main Results:

  • MMP-9 is secreted by leukocytes, cardiomyocytes, fibroblasts, and endothelial cells during cardiac repair.
  • MMP-9 modulates inflammation, promoting resolution and cell transition.
  • MMP-9 influences neovascularization and scar stiffness.

Conclusions:

  • MMP-9 has a dual role in cardiac wound healing, with both beneficial and detrimental effects.
  • Targeting MMP-9 requires a nuanced approach, focusing solely on its harmful actions.
  • Understanding downstream signaling pathways of MMP-9 is crucial for developing effective therapies.